Ce
Not verified

Celltrion

What we write about

BiotechnologyHealthIndustriaMedicine - variousPharmaceuticals
25/02/2025
Scienza
Marketing
Communication
Medicine - various
Biotechnology
Sanità
Health
Pharmaceuticals
Industria
Celltrion riceve l'autorizzazione della CE per Avtozma® (CT-P47), un farmaco biosimilare di RoActemra® (tocilizumab)
1.00
23/02/2025
Scienza
Marketing
Communication
Medicine - various
Biotechnology
Sanità
Health
Pharmaceuticals
Industria
Celltrion Receives EC Approval for Avtozma® (CT-P47), a Biosimilar to RoActemra® (tocilizumab)
1.00

Contact details

Social Media

Followers
0
Compatibility
0